Patents by Inventor John Philip Dirlam

John Philip Dirlam has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Macrolides
    Patent number: 7015203
    Abstract: The invention relates to novel erythromycin analogs and azalides, particularly ones with novel C-13 substituents, and to pharmaceutically acceptable salts thereof. The compounds of this invention are antibacterial agents that may be used to treat various bacterial and protozoa infections. The invention also relates to pharmaceutical compositions containing such compounds and to methods of treating bacterial protozoa infections by administering such compounds. The invention also relates to methods of preparing such compounds and to intermediates useful in such preparation.
    Type: Grant
    Filed: July 30, 2002
    Date of Patent: March 21, 2006
    Assignee: Pfizer Inc.
    Inventors: John Philip Dirlam, Hamish Alastair Irvine McArthur, Alan Elwood Blize
  • Novel macrolides
    Publication number: 20040092459
    Abstract: The invention relates to novel erythromycin analogs and azalides, particularly ones with novel C-13 substituents, and to pharmaceutically acceptable salts thereof. The compounds of this invention are antibacterial agents that may be used to treat various bacterial and protozoa infections. The invention also relates to pharmaceutical compositions containing such compounds and to methods of treating bacterial protozoa infections by administering such compounds. The invention also relates to methods of preparing such compounds and to intermediates useful in such preparation.
    Type: Application
    Filed: July 30, 2002
    Publication date: May 13, 2004
    Applicant: Pfizer Inc.
    Inventors: John Philip Dirlam, Hamish Alastair Irvine McArthur, Alan Elwood Blize
  • Macrolides
    Patent number: 6472371
    Abstract: The invention relates to novel erythromycin analogs and azalides, particularly ones with novel C-13 substituents, and to pharmaceutically acceptable salts thereof. The compounds of this invention are antibacterial agents that may be used to treat various bacterial and protozoa infections. The invention also relates to pharmaceutical compositions containing such compounds and to methods of treating bacterial protozoa infections by administering such compounds. The invention also relates to methods of preparing such compounds and to intermediates useful in such preparation.
    Type: Grant
    Filed: May 23, 2000
    Date of Patent: October 29, 2002
    Assignee: Pfizer, Inc.
    Inventors: John Philip Dirlam, Hamish Alastair Irvine McArthur, Alan Elwood Blize
  • Azalides and methods of making same
    Patent number: 6270768
    Abstract: This invention relates to methods of preparing compounds of Formula 1: and to pharmaceutically acceptable salts and solvates thereof, and to methods for preparing same. The compounds of Formula 1 are antibacterial agents that may be used to treat various bacterial and protozoal infections, and may also be used to treat cancer. The invention also relates to pharmaceutical compositions comprising the compounds of Formula 1, and to methods of treating sbacterial and protozoal infections by administering compounds of Formula 1.
    Type: Grant
    Filed: January 26, 2000
    Date of Patent: August 7, 2001
    Assignee: Pfizer Inc
    Inventors: Thomas N. O'Connell, Brook K. Morse, Hamish Alastair Irvine McArthur, John Philip Dirlam